• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Systemic delivery of microRNA for therapy of IBD

Research Project

  • PDF
Project/Area Number 16K15590
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field General surgery
Research InstitutionOsaka University

Principal Investigator

Yamamoto Hiofumi  大阪大学, 医学系研究科, 教授 (30322184)

Project Period (FY) 2016-04-01 – 2018-03-31
Keywords炎症性腸疾患 / マイクロRNA / 樹状細胞 / スーパーアパタイト
Outline of Final Research Achievements

Although anti-TNF antibodies and immunosuppressive agents can achieve remission, recurrence is common in inflammatory bowel disease (IBD). Accordingly, novel therapeutic strategies are needed.The aim of this study was to establish microRNA-based therapy in an IBD model. For this purpose, we used microRNA-29 (miR-29) and a super carbonate apatite (sCA) nanoparticle as a drug delivery system. Injection of sCA-miR-29a-3p or -29b-3p into the tail veins of mice markedly prevented inflammation due to dextran sulfate sodium (DSS)-induced colitis. We found that sCA-negative control miR predominantly accumulated in CD11c+ dendritic cells (DCs) in the inflamed epithelium. RNA sequencing and Ingenuity Pathway Analysis revealed that miR-29a or -29b could inhibit interferon signaling pathways. Injection of sCA-miR-29b efficiently targeted CD11c+DCs in the inflamed mucosa. The present study showed that systemic delivery of miR-29 prevented DSS-induced colitis.

Free Research Field

消化器疾患

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi